Retracted - miR-423-5p knockdown enhances the sensitivity of glioma stem cells to apigenin through the mitochondrial pathway
Authors:
Open Access
- 5 April 2017
- journal article
- retracted article
- Published by SAGE Publications in Tumor Biology
- Vol. 39 (4)
Abstract
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.Keywords
This publication has 25 references indexed in Scilit:
- A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cellsJournal of Controlled Release, 2016
- MicroRNA-145 Regulates Neural Stem Cell Differentiation Through the Sox2–Lin28/let-7 Signaling PathwayStem Cells, 2016
- CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186Oncotarget, 2015
- miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1Tumor Biology, 2014
- In Vivo Modeling of Malignant Glioma2014
- miR-125b Inhibitor May Enhance the Invasion-Prevention Activity of Temozolomide in Glioblastoma Stem Cells by Targeting PIAS3BioDrugs, 2013
- MicroRNA-21 Inhibitor Sensitizes Human Glioblastoma U251 Stem Cells to Chemotherapeutic Drug TemozolomideJournal of Molecular Neuroscience, 2012
- Pharmacogenomics genes show varying perceptibility to microRNA regulationPharmacogenetics and Genomics, 2011
- MicroRNAs and PharmacogenomicsPharmacogenomics, 2010
- MicroRNA Polymorphisms: the Future of Pharmacogenomics, Molecular Epidemiology and Individualized MedicinePharmacogenomics, 2009